title: Parkinsonism with intramuscular ziprasidone.
authors.forename: Louai
authors.initials: L
authors.lastname: Bilal
authors.forename: Carloine
authors.initials: C
authors.lastname: Tsai
authors.forename: James J
authors.initials: JJ
authors.lastname: Gasper
authors.forename: J Charles
authors.initials: JC
authors.lastname: Ndlela
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012563:Schizophrenia, Paranoid / Q000188:drug therapy* / Q000523:psychology; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D014754:Violence / Q000517:prevention & control
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone